SEC Form 4 · accession 0001209191-15-009206
LEMAITRE VASCULAR INC · LMAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter R Gebauer
Officer — President, International OP
Period of report
Jan 30, 2015
Accepted (ET)
Feb 3, 2015 · 9:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001158895
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 30, 2015 | M | 11,281 | $0.102 | A | 53,147 | D | |
| Common StockF2,F3 | Jan 30, 2015 | S | 11,281 | $7.9214 | D | 41,866 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4,F5 | $0.102 | Jan 30, 2015 | M | 11,281 | D | Jun 2, 1997 | Jun 2, 2007 | Common Stock | 11,281 | 162,189 | D |
Explanation of responses
- F1Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- F2This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- F3The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $7.90 to $7.99. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- F4This option is fully vested and exercisable.
- F5This stock option was originally reported on Form 3 as having an expiration date of June 2, 2007, but does not in fact have an expiration date. Because an expiration date is required to be reported, the originally reported expiration date is included for the sake of consistency.